- Home
- ONEW vs NBP Comparison
ONEW vs NBP Comparison
Compare ONEW & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONEW | NBP |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | 30 |
| Industry | Auto & Home Supply Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.6M | 173.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ONEW | NBP |
|---|---|---|
| Price | $11.76 | $1.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $16.50 | $9.00 |
| AVG Volume (30 Days) | 84.9K | ★ 460.0K |
| Earning Date | 04-30-2026 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.77 | N/A |
| Revenue | ★ $1,872,334,000.00 | N/A |
| Revenue This Year | $0.30 | N/A |
| Revenue Next Year | $3.14 | N/A |
| P/E Ratio | $4.16 | ★ N/A |
| Revenue Growth | ★ 5.62 | N/A |
| 52 Week Low | $8.12 | $1.46 |
| 52 Week High | $17.92 | $5.19 |
Technical Indicators
Market Signals| Indicator | ONEW | NBP |
|---|---|---|
| Relative Strength Index (RSI) | 59.39 | 42.77 |
| Support Level | $10.06 | N/A |
| Resistance Level | $12.14 | $1.67 |
| Average True Range (ATR) | 0.66 | 0.11 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 87.26 | 72.23 |
Price Performance
Historical ComparisonAbout ONEW OneWater Marine Inc.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.
About NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.